[DailyPharm = Reporter Choi Dae-eun] PYDERIN, a medical skincare brand, is attracting attention as its new product, '100day large-capacity cream,' from its pharmacy-exclusive line 'REJUVUSTER,' sold out in pharmacies nationwide within a week of its launch.
'REJUVUSTER 100day' is a large-capacity package consisting of 100 1ml sachets, characterized by its hygiene and portability, designed for daily use of one sachet. The analysis suggests that its convenient form for travel or outings enhanced consumer convenience and led to strong initial sales.
This product is a pharmacy-exclusive medical skincare based on PDRN derived from domestic salmon DNA. It applies 99% high-purity PDRN and a 97kDa ultra-low molecular weight design. Furthermore, it emphasizes functionality with a high-content formulation of 10,000ppm.
The response from pharmacies has also been rapid. A pharmacy official in a major commercial district in Seoul said, "The initial stock sold out quickly after launch, and inquiries for restock are continuing. The purchasing demographic is expanding to include not only demand for skin recovery after procedures but also consumers looking for daily high-functional skincare."
PYDERIN stated, "The strategy of expanding PDRN-based skincare, which was primarily centered in hospitals and clinics, to the pharmacy channel was effective. We are currently increasing production volume and plan to stabilize supply as soon as possible."
Meanwhile, 'REJUVUSTER' is an exclusive product sold only in pharmacies nationwide and is not distributed online.
